Final analysis of a phase II study of nivolumab in combination with ipilimumab for unresectable chemotherapy‐naive advanced melanoma

Nivolumab plus ipilimumab combination is currently one of the preferred regimens for advanced melanoma in recently updated clinical practice guidelines. However, the evidence on the efficacy of the combination for acral or mucosal subtypes remains less robust. This is the final analysis of a multice...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Dermatol
Main Authors: Namikawa, Kenjiro, Kiyohara, Yoshio, Takenouchi, Tatsuya, Uhara, Hisashi, Uchi, Hiroshi, Yoshikawa, Shusuke, Takatsuka, Sumiko, Koga, Hiroshi, Wada, Naoko, Minami, Hironobu, Hatsumichi, Masahiro, Namba, Yoshinobu, Yamazaki, Naoya
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7693067/
https://ncbi.nlm.nih.gov/pubmed/32812243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1346-8138.15514
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados